WHO reviews highlight limited long-term data on GLP-1 drug safety
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies…
Exercise can mitigate depression-like behaviors induced by high-fat, high-sugar diets
Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise…
Using a lab-designed protein to regulate blood glucose levels
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels…
GLP-1 therapeutics may have the potential to treat alcohol and drug addiction
A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
Exercise found to reduce artery hardening after weight loss in adults with obesity
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…